CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Total
Members Equity (Deficiency) [Member]
Deferred Compensation [Member]
Common Stock [Member]
Preferred Stock B [Member]
Preferred Stock A [Member]
Additional Paid-In Capital [Member]
Deficit Accumulated During the Development Stage [Member]
Balance at Jan. 21, 1997                        
Balance, shares at Jan. 21, 1997                   
Equity contributions 1,143,487 1,143,487                  
Subscriptions receivable 440,000 440,000                  
Technology contribution 4,550,000 4,550,000                  
Net loss (5,256,012)                   (5,256,012)
Balance at Dec. 31, 1997 877,475 6,133,487                (5,256,012)
Balance, shares at Dec. 31, 1997                   
Equity contributions 2,518,236 2,518,236                  
Options issued to consultants 1,671 1,671                  
Subscriptions receivable 50,000 50,000                  
Net loss (1,867,348)                   (1,867,348)
Balance at Dec. 31, 1998 1,580,034 8,703,394                (7,123,360)
Balance, shares at Dec. 31, 1998                   
Equity contributions 1,382,782 1,382,872                  
Equity issued to consultants 88,363 88,363                  
Recognition of deferred compensation    47,001 (47,001)               
Amortization of deferred compensation 15,667    (15,667)               
Subscriptions receivable 100,000 100,000                  
Net loss (3,066,388)                   (3,066,388)
Balance at Dec. 31, 1999 100,548 10,321,630 (31,334)             (10,189,748)
Balance, shares at Dec. 31, 1999                   
Equity contributions 14,047,916 14,407,916                  
Equity issued to consultants 1,070,740 1,070,740                  
Warrants issued to consultants 468,526 468,526                  
Recognition of deferred compensation    27,937 (27,937)               
Amortization of deferred compensation 46,772    46,772               
Net loss (10,753,871)                   (10,753,871)
Balance at Dec. 31, 2000 5,340,631 26,296,749 (12,499)             (20,943,619)
Equity contributions 13,411,506 13,411,506                  
Equity issued to consultants 161,073 161,073                  
Stock options issued to employee   2,847                  
Fees incurred in raising capital 1,206,730 1,206,730                  
Amortization of deferred compensation 12,499    12,499               
Net loss (15,392,618)                   (15,392,618)
Balance at Dec. 31, 2001 2,329,208 38,665,445                (36,336,237)
Equity contributions 6,739,189 6,739,189                  
Equity issued to consultants 156,073 156,073                  
Options issued to consultants 176,250 176,250                  
Stock options issued to employee   2,847                  
Fees incurred in raising capital 556,047 556,047                  
Conversion of convertible notes to common (1,350,828) (1,350,828)                  
Net loss (11,871,668)                   (11,871,668)
Balance at Dec. 31, 2002 (4,374,976) 43,832,929                (48,207,905)
Balance, shares at Dec. 31, 2002                   
Equity contributions 4,067,250 4,067,250                  
Equity issued to consultants 16,624 16,624                  
Change in fair value of management units 2,952,474 2,952,474                  
Options issued to consultants 65,681 65,681                  
Fees incurred in raising capital 343,737 343,737                  
Conversion of convertible notes to common (281,340) (281,340)                  
Net loss (6,009,283)                   (6,009,283)
Balance at Dec. 31, 2003 (3,907,307) 50,309,881                (54,217,188)
Balance, shares at Dec. 31, 2003                   
Equity contributions 512,555 512,555                  
Change in fair value of management units (2,396,291) (2,396,291)                  
Fees incurred in raising capital 80,218 80,218                  
Net loss (1,096,689)                   (1,096,683)
Balance at Dec. 31, 2004 (6,967,944) 48,345,927                (55,313,871)
Balance, shares at Dec. 31, 2004                   
Equity contributions 92,287 92,287                  
Change in fair value of management units (14,551) (14,551)                  
Fees incurred in raising capital 92,287 92,287                  
Reorganization from LLC to "C" Corporation    (49,219,260)    4,829       49,214,431   
Reorganization from LLC to "C" Corporation, shares       4,829,120          
Conversion of convertible notes to common 51,565 51,565                  
Issuance of common stock in settlement of accounts payable 836,319 836,319                  
Net loss (3,665,596)                   (3,665,596)
Balance at Dec. 31, 2005 (9,760,207)       4,829       49,214,431 (58,979,467)
Balance, shares at Dec. 31, 2005       4,829,120          
Stock based compensation - employees, consultants and directors 620,563                (620,563)   
Warrants issued to consultants 9,883                9,883   
Issuance of warrants 192,311                192,311   
Issuance of Series A Preferred Stock as dividends                303 303,397 (303,700)
Issuance of Series A Preferred Stock as dividends, shares             303,700    
Issuance of preferred stock 5,300,000             5,300 5,530,143 (235,443)
Issuance of preferred stock, shares             5,300,000    
Issuance of preferred stock for redemption of convertible note 1,000,000             1,000 1,204,640 (205,640)
Issuance of preferred stock for redemption of convertible note, shares             1,000,000    
Issuance of stock options to employees, consultants and directors 143,352                143,352   
Shares held by original stockholders of Parent immediately prior to merger          3,750       (3,750)   
Shares held by original stockholders of Parent immediately prior to merger, shares       3,750,000          
Conversion of stock          (241)    800 30,194 (30,753)
Conversion of stock, shares       (240,929)    799,885    
Issuance of common stock         241       799,644   
Issuance of common stock, shares       240,929          
Issuance of common stock to investor group for price protection          100       (100)   
Issuance of common stock to investor group for price protection, shares       100,000          
Issuance of common stock in consideration for funding $1,000,000 convertible note payable per terms of merger transaction 1,000,000       10,000       587,035   
Issuance of common stock in consideration for funding $1,000,000 convertible note payable per terms of merger transaction, shares       10,000,000          
Conversion of convertible notes to common 11,382,110       5,171       11,376,939   
Conversion of convertible notes to common, shares       5,170,880          
Cost of raising capital (620,563)                5,530,143 (235,443)
Cost of raising capital, shares                   
Issuance of common stock in settlement of accounts payable 587,814       779       587,035   
Issuance of common stock in settlement of accounts payable, shares       778,274          
Net loss (7,671,580)                   (7,671,580)
Balance at Dec. 31, 2006 2,363,005       24,629    7,403 69,757,556 (67,426,583)
Balance, shares at Dec. 31, 2006       24,628,274    7,403,585    
Stock based compensation - employees, consultants and directors 498,955                498,955   
Conversion of stock          405    (506) 101   
Conversion of stock, shares       405,157    (506,446)    
Issuance of common stock in settlement of accounts payable 23,002       11       22,991   
Issuance of common stock in settlement of accounts payable, shares       11,501          
Issuance of Series A Preferred Stock as dividends and settlement of dividends/penalties payable in connection with non-registration event (361,496)             1,122 1,121,246 (760,872)
Issuance of Series A Preferred Stock as dividends and settlement of dividends/penalties payable in connection with non-registration event, shares             1,122,369    
Net loss (3,350,754)                   (3,350,754)
Balance at Dec. 31, 2007 (104,296)       25,045    8,019 71,400,849 (71,538,209)
Balance, shares at Dec. 31, 2007       25,044,932    8,019,508    
Stock based compensation - employees, consultants and directors 363,563                363,563   
Issuance of warrants 40,354                40,354   
Issuance of Series A Preferred Stock as dividends                831 277,087 (277,918)
Issuance of Series A Preferred Stock as dividends, shares             830,384    
Issuance of preferred stock (5,293,148)          53    5,657,842 (364,747)
Issuance of preferred stock, shares          52,931.47       
Issuance of Series B Preferred Stock as dividends             2    262,715 (262,717)
Issuance of Series B Preferred Stock as dividends, shares          2,627.17       
Conversion of stock          219    (57) (162)   
Conversion of stock, shares       218,585    (56,832)    
Cost of raising capital (215,398)                (215,398)   
Cost of raising capital, shares                   
Net loss (3,017,890)                   (3,017,890)
Balance at Dec. 31, 2008 2,359,481       25,264 55 8,793 77,786,850 (75,461,481)
Balance, shares at Dec. 31, 2008       25,263,517 55,558.64 8,793,060    
Stock based compensation - employees, consultants and directors 236,705                236,705   
Issuance of Series A Preferred Stock as dividends                789 110,809 111,598
Issuance of Series A Preferred Stock as dividends, shares             789,610    
Issuance of Series B Preferred Stock as dividends             6    586,017 (586,023)
Issuance of Series B Preferred Stock as dividends, shares          5,860.22       
Conversion of notes payable and accrued interest to Series B Preferred Shares            1    64,308 (6,704)
Conversion of notes payable and accrued interest to Series B Preferred Shares, shares          576.05       
Conversion of stock          41,111 (6) (3,326) (37,779)   
Conversion of stock, shares       41,111,339 (6,628.55) (3,326,857)    
Conversion of convertible notes to common 57,605              
Cashless exercise of warrants 1,335,754          13    1,335,741   
Cashless exercise of warrants, shares          13,357.52       
Warrant modification as inducement to exercise 14,885                14,885   
Net loss (2,736,715)                   (2,736,715)
Balance at Dec. 31, 2009 1,267,715       66,375 69 6,256 80,097,536 (78,902,521)
Balance, shares at Dec. 31, 2009       66,374,856 68,723.88 6,255,813    
Stock based compensation - employees, consultants and directors 149,325                149,325   
Issuance of Series A Preferred Stock as dividends                590 167,992 (168,582)
Issuance of Series A Preferred Stock as dividends, shares             590,159    
Issuance of Series B Preferred Stock as dividends             6    2,008,876 (2,008,882)
Issuance of Series B Preferred Stock as dividends, shares          6,232.81       
Conversion of stock          47,824 (14) (1,020) (46,790)   
Conversion of stock, shares       47,824,298 (13,983.58) (1,019,563)    
Issuance of common stock 749,999       7,174       742,825   
Issuance of common stock, shares       7,174,186          
Cost of raising capital (49,560)       1,465       (51,025) (49,560)
Cost of raising capital, shares       1,465,071          
Relative fair value of warrants and beneficial conversion feature in connection with issuance of convertible note 306,805                306,805   
Net loss (2,908,865)                   (2,908,865)
Balance at Dec. 31, 2010 (484,581)       122,838 61 5,826 83,375,544 (83,988,850)
Balance, shares at Dec. 31, 2010       122,838,411 60,973.11 5,826,409    
Stock based compensation - employees, consultants and directors 865,535                865,535   
Issuance of Series A Preferred Stock as dividends                266 71,755 (72,021)
Issuance of Series A Preferred Stock as dividends, shares             266,161    
Issuance of Series B Preferred Stock as dividends             6    3,015,017 (3,015,023)
Issuance of Series B Preferred Stock as dividends, shares          6,283.41       
Conversion of stock          16,116 (2) (4,645) (11,469)   
Conversion of stock, shares       16,115,042 (1,823.18) (4,645,411)    
Issuance of common stock 2,643,766       17,336       2,626,430   
Issuance of common stock, shares       17,335,942          
Conversion of convertible notes to common 1,515,130       15,151       1,499,979   
Conversion of convertible notes to common, shares       15,151,310          
Relative fair value of warrants and beneficial conversion feature in connection with issuance of convertible note 1,250,000                1,250,000   
Cashless exercise of warrants          6,013       (6,013)   
Cashless exercise of warrants, shares       6,013,478          
Exercise of stock options 5,141       147       4,994   
Exercise of stock options, shares       146,875          
Issuance of common stock in settlement of accounts payable 5,000       25       4,975   
Issuance of common stock in settlement of accounts payable, shares       25,000          
Net loss (5,481,648)                   (5,481,648)
Balance at Dec. 31, 2011 318,343       177,626 65 1,447 92,696,747 (92,557,542)
Balance, shares at Dec. 31, 2011       177,626,058 65,433.34 1,447,159    
Stock based compensation - employees, consultants and directors 16,964                16,964   
Issuance of Series A Preferred Stock as dividends 1,870,846             111 12,937 (13,048)
Issuance of Series A Preferred Stock as dividends, shares             111,125    
Issuance of Series B Preferred Stock as dividends             5    12,937 (1,857,798)
Issuance of Series B Preferred Stock as dividends, shares          5,022.93       
Conversion of stock          419    (3) (416)   
Conversion of stock, shares       418,633 (140.87) (3,003)    
Issuance of common stock 3,210,153       24,828       3,185,325   
Issuance of common stock, shares 3,210,153     24,828,903          
Conversion of convertible notes to common 685,208       6,852       678,356   
Conversion of convertible notes to common, shares       6,852,088          
Relative fair value of warrants and beneficial conversion feature in connection with issuance of convertible note 87,700                87,700   
Cashless exercise of warrants          170       (170)   
Cashless exercise of warrants, shares       169,762          
Exercise of stock options                 
Net loss (3,125,886)                   (3,125,886)
Balance at Sep. 30, 2012 $ 1,192,482       $ 209,895 $ 70 $ 1,555 $ 98,535,236 $ (97,554,274)
Balance, shares at Sep. 30, 2012       209,895,444 70,315.40 1,555,281